Exacerbations · the management of chronic obstructive pulmonary disease
1 finding from 1 review
Impact on health behaviour: 6MWD · the management of chronic obstructive pulmonary disease
1 finding from 1 review
Quality of life St George's Respiratory Questionnaire (SGRQ) score · the management of chronic obstructive pulmonary disease
1 finding from 1 review
Exacerbations (number of people experiencing ≥ 1 exacerbations) · the management of chronic obstructive pulmonary disease
It is very uncertain whether multi‐component intervention changes exacerbations: number of people experiencing at least one exacerbation compared with other intervention or routine, usual care or control treatment (very low certainty).
1 finding from 1 review
Diabetes · Adults with mental disorders in low‐ and middle‐income countries
Atypical showed no clear difference in diabetes (ADA criteria) (6 weeks) compared with typical antipsychotic medications (low certainty).
1 finding from 1 review
Diabetes · Adults with mental disorders in low‐ and middle‐income countries
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Drop‐out Objective · Adults with mental disorders in low‐ and middle‐income countries
Melatonin showed no clear difference in drop‐outs (8 weeks) compared with placebo (low certainty).
1 finding from 1 review
Fasting blood glucose (mg/dL) · Adults with mental disorders in low‐ and middle‐income countries
1 finding from 1 review
Fasting blood glucose (8 to 12 weeks) (change from baseline data) · Adults with mental disorders in low‐ and middle‐income countries
1 finding from 1 review
Body‐mass index (BMI) · Adults with mental disorders in low‐ and middle‐income countries
1 finding from 1 review
Diabetes · Adults with mental disorders in low‐ and middle‐income countries
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Drop‐out Objective · Adults with mental disorders in low‐ and middle‐income countries
It is very uncertain whether SSRI antidepressants changes drop‐outs (12 weeks) compared with TCA (very low certainty).
1 finding from 1 review
Fasting blood glucose (mg/dL) · Adults with mental disorders in low‐ and middle‐income countries
1 finding from 1 review
Body‐mass index (BMI) · Adults with mental disorders in low‐ and middle‐income countries
1 finding from 1 review
Drop‐out Objective · Adults with mental disorders in low‐ and middle‐income countries
Atypical showed no clear difference in drop‐outs (6 to 54 weeks) compared with typical antipsychotic medications (low certainty).
1 finding from 1 review
Fasting blood glucose (mg/dL) · Adults with mental disorders in low‐ and middle‐income countries
1 finding from 1 review
Body‐mass index (BMI) · Adults with mental disorders in low‐ and middle‐income countries
1 finding from 1 review
Intervention not reported
Outcomes No of participants (studies)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Incidence of delirium during hospital admission validated diagnostic instruments1 3693 participants (14 studies)
The intervention probably leads to lower incidence of delirium during hospital admission validated diagnostic… (moderate certainty).
1 finding from 1 review
Intervention not reported
Inpatient mortality 2640 participants (10 studies)
The intervention showed no clear difference in inpatient mortality 2640 participants (10 studies) (low certainty).
1 finding from 1 review